Michael Jorrin, "Doc Gumshoe"

Author Bio

Michael Jorrin,
I have been a medical writer for about 25 years; before that I was a documentary film maker, and some of my films were about medical subjects. I am not a physician, but I have a pretty good scientific background. I wouldn’t dream of recommending any kind of treatment to anyone, and I cannot give medical advice. However, I understand the medical literature and the data and evidence behind it, and I have an inquiring and skeptical turn of mind. I scrutinize and question and, sometimes, challenge the positions of some of the established health-care organizations as well as the marketers of health information. Eternal vigilance is a small price to pay for health. — Michael Jorrin (aka DocGumshoe) Michael Jorrin is a paid contributor to Stock Gumshoe, he has agreed to our trading restrictions but he chooses his own topics and his words and opinions are his own.

Author Archives

Chances are not many of us observed New Year’s Eve with celebratory toasts to the glorious year gone by.   Rather, we bid goodbye to 2018 and hoped 2019 would be a better year – for ourselves, our near and dear, our country, and our planet.   However, as I wade through the volumes of healthcare-related stuff […]

I’ll grant that my headline is meant to be catchy and induce you to read this epistle.   Some of you will ask what is ketamine anyway, and most of you will know from the get-go that ketamine, whatever the heck it is, will turn out to be neither a menace nor a miracle, but something […]

Let’s lead off with a news item that Doc Gumshoe, despite his widely-acknowledged acumen, could not manage to figure out in the least.   It took an Op Ed in the N Y Times to sweep the cobwebs out of his noggin.    The news item was this: children born in the month of August […]

I’m not going to keep you in suspense.   The two proposed miracle cures are L-carnitine (an amino acid) and “Delta 8,” which in a previous Doc Gumshoe disquisition was unmasked as Delta 8 tetrahydrocannabinol, or Delta 8 THC (Δ8 THC), which is one of perhaps a hundred cannabinoids found in the cannabis plant, as […]

Most of the attention in the media is now focused on the several forms of cancer treatment grouped under the flattering term “Precision Medicine.”   I find that the term raises my skepticism index just a bit; it’s like eating establishments labeling themselves “Gourmet Restaurants,” the implication being that joints not so identified are just […]

Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me.   Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy?   But I probably pay more attention to […]

For those of us who live in this part of the country and spend any time messing around outdoors in the grass and weeds, this is the time to be careful about Lyme disease. I had a bout of Lyme 16 years ago, and it descended on me when we were on vacation, driving through […]

Is this going to be good news, or bad news, or somewhere in between?   On balance, I would say good news, simply because the research and investigation is going on at an intense pace.   Currently there are 1,903 clinical trials underway at some stage, in the US and all over the world. When I first […]

When I last took a look at what was happening in the treatment of migraines, I took careful pains to elucidate the differences between migraines and a plain old bad headache – the fact that migraines affect only one side of the head, and a detailed disquisition on the symptoms that many migraineurs (that’s the […]

No, these bits won’t be about Melania’s kidney ailment nor yet about what Meghan wore for The Wedding.   I wish them both luck – they’ll need it!. However, there continue to be developments on the medical and health-care fronts that may matter to us a good deal more than the doings of those ladies.    […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investments. His ideas, thoughts and words are his own, […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

[ed. note: Michael Jorrin, who I call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes for us about medicine and health a couple times a month. He has agreed to our trading and disclosure restrictions, but does not generally write directly about investment ideas. His ideas, thoughts and words are his […]

[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues, marketing, and trends. He does not typically focus on specific investment opportunities, but has agreed to our trading restrictions… as with all of our […]

Recent Author Comments

On Doc Gumshoe – COVID-19 Miscellany, May 2020

I was surprised and somewhat overwhelmed by the volume of comments about the Doc Gumshoe “COVID 19 Miscellany” post. I’m taking the liberty (for which I hope you will forgive me) of addressing several points in a single response. Re the comment st[...]

Go to Comment »
On Doc Gumshoe – COVID-19 Miscellany, May 2020

At this time, it’s not known whether the particular corona virus that causes COVID 19 mutates frequently or only occasionally or not at all. Even if it were to mutate, a vaccine against SARS-CoV-2 would likely decrease the harmful effects of the diseas[...]

Go to Comment »
On What's "The One-Hour Fix for Memory Loss?"

I've had my eye on Actinogen for some time, but I missed that release from the company. I'll give it another look - thanks very much.[...]

Go to Comment »
On What's "The One-Hour Fix for Memory Loss?"

Thanks very much for the suggestion that I repeat my conclusions at the end in bullet form.! I'll try to remember that, even without the assistance of curcumin.[...]

Go to Comment »
On What's "The One-Hour Fix for Memory Loss?"

I didn't exactly recommend Theracurmin - I just said that, in contrast with Brain Booster Plus, it deserved consideration. If I decided to try it myself, I would report back to you in 18 months or so. Sorry if my piece was overlong - I wanted to let t[...]

Go to Comment »
On What's "The One-Hour Fix for Memory Loss?"

The legitimate research that I could find supports Theracurmin, but not Brain Booster Plus. I mentioned that in my article. Whichever you pick, best of luck. And please keep us posted regarding the outcome![...]

Go to Comment »
On What's Bonner's "FDA Fast Tracks $6.8 Billion Miracle Antibiotic" pitch about?

Tebipenem will likely get the FDA nod, but it's far from being the most powerful antibiotic ever. It's a carbapenem and there are several others in the market that are being used regularly. The 2009 approval in Japan was for pediatric use only. Spero[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

Could be - current estimates are that 21% of New York City residents may have been infected. Can't say whether that would translate to 85 times greater infection rate overall. Different states come up with their figures in different ways - some track c[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

And by the way, today the American Journal of Medicine had this to say about the hydroxychloroquine and the HCZ/azithromycin combo: “The NIH convened an expert medical panel that recommended against using a drug combination of the antibiotic azithromyc[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

Yes, ivermectin prevented the coronavirus from replicating in vitro, but the concentrations needed to achieve that goal were the equivalent of doses 50 to 100 times greater than the FDA-approved doses. This was reported in the paper describing the Austr[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

HCQ is indeed used for systemic lupus erythematosus and has been shown to help control not just skin symptoms but systemic complications of lupus such as kidney diseases (lupus nephritis). Good luck with your lupus & stay well.[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

COVID 19 is not flu. The influenza virus is distinct and has been well sequenced in its various mutations. Some coronaviruses cause ordinary colds - upper respiratory infections. This particular one is related to the two coronaviruses that caused the[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

The coronavirus - SARS CoV-2 = has been mapped thoroughly, including it's dozen surface proteins and major sections of its 30,000 base pair RNA sequence. It's not cellular debris. Sorry.[...]

Go to Comment »
On COVID 19 Update and Other Brief Bits

From what I have seen, i's extremely early days for leronlimab. Only one patient from their very small trial - 15 in the cohort - has responded. It's a good sign, but the information is pre-preliminary.[...]

Go to Comment »
On Brief Bulletins of Interest

Lysol is a disinfectant, not an antimicrobial or antiviral Yes, it will kill viruses on contact & also bacteria. But you don't want it inside your body. The digital examination tells the examiner if there are little knobs of something in the gland, [...]

Go to Comment »
On Coronavirus Update – February 2020

Italy - 3 cases, zero deaths - may it stay that way![...]

Go to Comment »
On Coronavirus Update – February 2020

Thanks - I'll check Inovio. There will keep on being new players, both in the antiviral and vaccine spaces. As for the conspiracy theories, they make my head spin![...]

Go to Comment »
On Warm Bits for a Cold Month

I totally agree with you. People in pain suffer unnecessarily while the addicts look for highs, occasionally overdosing and causing trouble for the community at large.[...]

Go to Comment »
On What's this "One Stock for the First Addiction-Proof Cure for Pain?"

How can it be a cannabinoid receptor agonist without affecting the brain, which is where the cannabinoid receptors dwell? What particular properties make it non-addictive? My guess is that when the maker says “non-addictive,” what that means is tha[...]

Go to Comment »
On Warm Bits for a Cold Month

Responses to comments about “Warm Bits…” I’ll say this right at the start: when Gumshoeland Denizens ask me for my views about something, I will follow up somehow. As in, “no, I have no opinion on immunomedics at the moment, but I’ll look in[...]

Go to Comment »

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch